Table 3.
Differences in acute COVID-19 symptom prevalence between participants reporting mild symptom burden and severe symptom burden.
| SARS-CoV-2 positive population |
||||
|---|---|---|---|---|
| Total population (n = 6630) | Self-reported mild symptom burden (n = 3795) | Self-reported severe symptom burden (n = 594) | p-valuea | |
| Fever, n (%) | 1768 (26.7) | 1383 (36.4) | 385 (64.8) | <0.0001 |
| Cold, n (%) | 1939 (29.3) | 1594 (42.0) | 345 (58.1) | <0.0001 |
| Sore throat, n (%) | 2063 (31.1) | 1677 (44.2) | 386 (65.0) | <0.0001 |
| Cough, n (%) | 2093 (31.6) | 1711 (45.1) | 382 (64.3) | <0.0001 |
| Stomach aches, n (%) | 568 (8.6) | 390 (10.3) | 178 (30.0) | <0.0001 |
| Rashes, n (%) | 105 (1.6) | 72 (1.9) | 33 (5.6) | <0.0001 |
| Trouble breathing, n (%) | 1129 (17.0) | 787 (20.7) | 342 (57.6) | <0.0001 |
| Reduced sense of smell, n (%) | 2398 (36.2) | 2002 (52.8) | 396 (66.7) | <0.0001 |
| Reduced sense of taste, n (%) | 2062 (31.1) | 1689 (44.5) | 373 (62.8) | <0.0001 |
| Chest pain, n (%) | 393 (5.9) | 232 (6.1) | 161 (27.1) | <0.0001 |
| Headaches, n (%) | 2597 (39.2) | 2118 (55.8) | 479 (80.6) | <0.0001 |
| Vomiting, n (%) | 139 (2.1) | 76 (2.0) | 63 (10.6) | <0.0001 |
| Diarrhoea, n (%) | 281 (4.2) | 197 (5.2) | 84 (14.1) | <0.0001 |
| Muscle pain, n (%) | 1234 (18.6) | 903 (23.8) | 331 (55.7) | <0.0001 |
| Joint pain, n (%) | 748 (11.3) | 522 (13.8) | 226 (38.1) | <0.0001 |
| Pain, n (%) | 448 (6.8) | 250 (6.6) | 198 (33.3) | <0.0001 |
| Feeling unwell, n (%) | 1652 (24.9) | 1252 (33.0) | 400 (67.3) | <0.0001 |
| Number of symptoms (median, interquartile range) | 2 (0–5) | 4 (2–6) | 8 (5–11) | <0.0001 |
a
Differences in prevalence of symptom between participants reporting mild and severe symptom burden tested using two-sided χ2-tests.